Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 23, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - July 23, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/22/17 - "Kinase Inhibitors" in Patent Application Approval Process (USPTO 20170183343)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors CAPALDI, Carmelida; ARMANI, Elisabetta; JENNINGS, Andrew Steven Robert; HURLEY, Christopher, filed on December 22, 2016, was made available online on July 6, 2017, according to news reporting originating from Washington, D.C., by NewsRx c
7/22/17 - Anti-Thrombin Activators Market: Upcoming Demands and Growth Analysis 2024
Transparency Market Research Report Added "Anti-thrombin Activators Market" to its database.Albany, NY 07/21/2017 Anti-thrombin activators are widely accepted due to their role in reducing thrombus formation. Anticoagulants, anti-platelet drugs, and thrombolytic drugs are some of the different types of anti-thrombin activators available, whic
7/22/17 - BrainStorm Wins $15.9M CIRM Grant for Phase III Trial of ALS Cell Therapy [Sport360]
BrainStorm Cell Therapeutics has won a $15.9 million grant from Californias regenerative medicine agency toward a Phase III trial of its amyotrophic lateral sclerosis cell therapy candidate NurOwn. NurOwn technology was developed in the laboratories of Dani Offen, Ph.D., and the late Eldad Melamed, M.D., at Tel Aviv University. BrainStorm said it i
7/22/17 - CHMP Recommends EU Approval for Roche's TECENTRIQ (Atezolizumab) in a Specific Type of Metastatic Lung and Two Types of Metastatic Bladder Cancer
Roche, a biotech company, issued the following news release:. Roche today announced that the EU Committee for Medicinal Products for Human Use has adopted a positive opinion for TECENTRIQ (R) as a monotherapy for the treatment of adults with locally advanced or metastatic non-small cell lung cancer after they have been previously treated with chemo
7/22/17 - Concert Pharmaceuticals, Lexington, Mass., Assigned Patent for Derivatives of Pyrazole-Substituted Amino-Heteroaryl Compounds
Concert Pharmaceuticals, Lexington, Massachusetts, has been assigned a patent developed by four co-inventors for "derivatives of pyrazole-substituted amino-heteroaryl compounds." The co-inventors are Bhaumik A. Pandya, Arlington, Massachusetts, Craig E. Masse, Cambridge, Massachusetts, Ian Robert Silverman, Arlington, Massachusetts, and Roger D. Tu
7/22/17 - Egalet Announces Pricing of Public Offering of Common Stock and Warrants
By a News Reporter-Staff News Editor at Marketing Weekly News Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, announced the pricing of its underwritten public offering of 16,666,667 shares of its common stock and...
7/22/17 - Ema's Chmp Issues Positive Opinion for Avelumab for Treatment of Metastatic Merkel Cell Carcinoma
Pfizer, a pharmaceutical company, issued the following news release:. Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of avelumab* as
7/22/17 - Global Outlook for Cold Plasma Market by Key Trends and Analysis 2026
Transparency Market Research Report Added "Cold Plasma Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016- 2026". Albany, NY 07/21/2017 Cold Plasma Market: Overview Cold plasma, popularly known as non-thermal plasma, is the new cutting edge concept that has wide applications in medical devices. The technology has
7/22/17 - Help Get Over-The-Counter Hearing Aids Act Passed
The growing influence of big-box stores such as Costco may make buying a hearing aid easier. By the way, Costco s optical and hearing aid departments both have licensed optometrists and hearing aid dispensers who are independent contractors and not Costco employees. The FDA prohibits manufacturers from marketing their products as hearing aids to
7/22/17 - Imaging Biomarkers Market - Positive Long-Term Growth Outlook 2023
Transparency Market Research Report Added "Imaging Biomarkers Market" to its database.Albany, NY 07/21/2017 An imaging biomarker is a biomarker that can be detected with the help of an imaging technology. Biomarkers are increasingly being applied as a diagnostic tool. According to the National Institutes of Health's National Cancer Institute,
7/22/17 - Janssen Receives Positive CHMP Opinion for SYMTUZA First Darunavir-Based Single-Tablet Regimen for Treatment of HIV
BEERSE, Belgium, July 21 Johnson and Johnson issued the following news release:. Janssen-Cilag International NV today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a Positive Opinion recommending marketing authorisation for SYMTUZA, a once-daily darunavir-based single tablet regimen.
7/22/17 - Sanofi, Regeneron Receive Positive CHMP Opinion for Dupixent (dupilumab) to Treat Adult Patients With Moderate-to-Severe Atopic Dermatitis
Sanofi, a life sciences company, issued the following news release:. Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for the marketing authorization of Dupixent (R), recommending its approval in Europe for use in adults with.
7/22/17 - Sen. Collins Secures Provision to Protect Prescription Paper Inserts
U.S. Senator Susan Collins announced today that the Senate Appropriations Committee approved language she authored to continue to protect prescription paper inserts. The provision was included as part of the fiscal year 2018 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations bill at the request of Senat
7/22/17 - Sen. Grassley, Bipartisan Drug Affordability Cosponsors Urge FDA Commissioner to Reform Anticompetitive Drug Practices
Senate Judiciary Committee Chairman Chuck Grassley alongside Senators Patrick Leahy, Mike Lee, and Amy Klobuchar are asking Food and Drug Administration Commissioner Scott Gottlieb to address anticompetitive practices currently used by some brand-name pharmaceutical companies to delay the manufacture and introduction of generic drugs in the...
7/22/17 - Sen. Leahy, Bipartisan Drug Affordability CREATES Act Cosponsors Urge FDA Commissioner to Reform Anticompetitive Drug Practices
U.S. Senator Patrick Leahy, joined by Senators Chuck Grassley, Amy Klobuchar, and Mike Lee, are asking Food and Drug Administration Commissioner Scott Gottlieb to address anticompetitive practices currently used by some brand-name pharmaceutical companies to delay the manufacture and introduction of generic drugs in the market. The senators wrote:
7/22/17 - Sens. Klobuchar, Lee Urge FDA to Consider Temporary Importation to Lower Prices on Prescription Drugs That Face Little or No Competition
Under the Short on Competition Act, the FDA could allow a company to sell a drug that faces little or no competition in the U.S. if the company already had approval to sell it in another country with similar safety requirements to the U.S and if the product has been on the market in that country for at least ten years. As a result, a company could
7/22/17 - Takeda explores computational chemistry leads from Schrdinger in $170M-plus pact; Aeterna Zentaris boots CEO, considers options [Arab Times (Kuwait)]
Three months after Aeterna Zentaris$ AEZS saw its shares crater on the news that its big Phase III study for Zoptrex had failed, the company has booted CEO David Dodd and replaced him with Michael Ward, a former exec for Sagent. Earlier in the week the biotech noted that the FDA had accepted its new NDA for Macrilen, overcoming its initial rejectio
7/21/17 - "Method for Producing Synthetic Pentapeptide" in Patent Application Approval Process (USPTO 20170183307)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors MURAYAMA, Asami; KANO, Takaaki, filed on December 19, 2014, was made available online on July 6, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Maruishi Pharmaceutical Co.,
7/21/17 - ACETO Subsidiary, Rising Pharmaceuticals, Announces Product Launches
ACETO Corporation, an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, recently launched:. Ramipril Capsules, 1.25 mg, 2.5 mg, 5 mg, and 10 mg,
7/21/17 - Aeterna Zentaris Inc. - NDA for Macrilen for the Evaluation of Growth Hormone Deficiency in Adults Granted December 30, 2017 PDUFA Date
Release date- 20072017- CHARLESTON, S.C.- Aeterna Zentaris Inc. today announced that it has been notified by the U.S. Food and Drug Administration, that the Company's New Drug Application seeking approval of Macrilen for the evaluation of growth hormone deficiency in adults has been accepted as a complete response to the FDA's November 5, 2014 Comp
7/21/17 - AEZS Gets Down To Serious Work, APVO Surges, FDA Tentative Nod For MRK
THOUSAND OAKS- Today's Daily Dose brings you news about Aeterna's leadership change; Aptevo's agreement with Alligator Bioscience; Amgen's regulatory catalyst related to migraine med Aimovig; Diffusion Pharma's milestone achievement; Incyte's progress in GRAVITAS-301 study and FDA's tentative nod for Merck. The Company's resubmitted New Drug...
7/21/17 - Alcon Research, Fort Worth, Texas, Assigned Patent for Pharmaceutical Suspension
Alcon Research, Fort Worth, Texas, has been assigned a patent developed by Bhagwati P. Kabra, Euless, Texas, for pharmaceutical suspension. The patent application was filed on Dec. 3, 2009. Written by Sudarshan Harpal; edited by Sudarshan Harpal.
7/21/17 - Alder Biopharmaceuticals Inc. Files SEC Form 8-K, Current Report (Jun. 30, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alder Biopharmaceuticals Inc. was posted on June 30, 2017. The SEC file number is 0001193125-17-220247.. A U.S. Securities and Exchange Commission filing is a f
7/21/17 - Amgen Says FDA Accepts BLA For Aimovig
THOUSAND OAKS- Amgen said that the U.S. Food and Drug Administration has accepted for review the Biologics License Application or BLA for Aimovig for the prevention of migraine in patients experiencing four or more migraine days per month. The FDA has set a Prescription Drug User Fee Act target action date of May 17, 2018. Aimovig will be jointly c
7/21/17 - ArQule To Report Second Quarter 2017 Financial Results On August 4, 2017
ArQule, Inc. today announced it will report financial results for the second quarter 2017 before the market opens on Friday, August 4, 2017. ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases. Our clinical-stage pipeline consists of five drug candidates, all of w
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415